Jeevan Scientific Technology LtdJeevan Scientific Technology Ltd
If turnaround succeeds and capital infusion is deployed effectively, the company could regain momentum in clinical research and pharma services.
₹30.74 crore fundraise via preferential issue of - 35 lakh convertible warrants at ₹40 each
41.85 lakh equity shares at ₹40 each.
Purpose of funds: Capital expenditure, Working capital support, Subsidiary expansion, Acquisition of API/formulation units, General corporate needs.
hopefully a 2X
